The abnormal expression and activity of DPP-4 has been observed to be associated with the occurrence of hyperglycemia and an increase in body mass index, implying that this enzyme may contribute to the development of diseases such as T2DM and obesity by mediating inflammation and insulin resistance in adipose tissue [48]. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.